YSB Past Earnings Performance
Past criteria checks 2/6
YSB's earnings have been declining at an average annual rate of -22.6%, while the Healthcare industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 14.8% per year.
Key information
-22.6%
Earnings growth rate
-5.2%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 14.8% |
| Return on equity | -0.8% |
| Net Margin | 0.007% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How YSB makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 17,817 | 1 | 1,815 | 99 |
| 31 Mar 24 | 17,395 | -1,594 | 1,766 | 96 |
| 31 Dec 23 | 16,972 | -3,189 | 1,717 | 94 |
| 30 Sep 23 | 16,248 | -3,605 | 1,676 | 88 |
| 30 Jun 23 | 15,524 | -4,022 | 1,636 | 83 |
| 31 Mar 23 | 14,899 | -2,755 | 1,625 | 81 |
| 31 Dec 22 | 14,275 | -1,489 | 1,615 | 79 |
| 31 Dec 21 | 10,094 | -494 | 1,273 | 57 |
| 31 Dec 20 | 6,065 | -572 | 886 | 25 |
Quality Earnings: 9885 has a large one-off gain of CN¥13.2M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 9885 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9885 has become profitable over the past 5 years, growing earnings by -22.6% per year.
Accelerating Growth: 9885 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 9885 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-11.6%).
Return on Equity
High ROE: 9885's Return on Equity (-0.8%) is considered low.